Skip to main content
. 2014 Sep 30;8:340. doi: 10.3389/fnbeh.2014.00340

Figure 5.

Figure 5

Effects of UCMS and 4 weeks treatment of fluoxetine (FLX 15 mg/kg/day ip) on cell proliferation and neurogenesis in the hippocampus. HS: High suppressers, LS: Low suppressers, VEH: vehicle, FLX: fluoxetine. (A) Densitiy of cell proliferation using ki-67 staining in the granule cell layer in the whole, dorsal, intermediate, and ventral hippocampus (whole, temporal and intermediate hippocampus: HS VEH (n = 9), HS FLX (n = 6), LS VEH (n = 7), LS FLX (n = 6); septal hippocampus: HS VEH (n = 7), HS FLX (n = 6), LS VEH (n = 7), LS FLX (n = 5)). (B) Density of immature neurons using doublecortin (DCX) labeling in the GCL (whole, temporal and intermediate parts: HS VEH (n = 5), HS FLX (n = 6), LS VEH (n = 6), LS FLX (n = 4); septal parts: HS VEH (n = 5), HS FLX (n = 5), LS VEH (n = 6), LS FLX (n = 4)). HS VEH vs. HS FLX: # p < 0.05, ### p < 0.001; HS FLX vs. LS FLX: * p < 0.05, ** p < 0.01.